Shopping Cart
- Remove All
- Your shopping cart is currently empty
SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE. |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.